The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study

Gastroenterology

Volumn 124, Issue 1, 2003, Pages 9-17

  Francella, Andrew ^a   Dyan, Alan ^a   Bodian, Carol ^a   Rubin, Peter ^a   Chapman, Mark ^a   Present, Daniel H ^a,b  

^a MOUNT SINAI HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE;

ADULT; ARTICLE; BIRTH DEFECT; CHILDBIRTH; COHORT ANALYSIS; CONCEPTION; CONGENITAL DISORDER; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; ENTERITIS; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS;

EID: 0037219412     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50014     Document Type: Article

References (52)

1. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1129-1137.
2. Baird DD, Narendranathan M. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-994.
3. Korelitz BI. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am 1992;21:827-834.
4. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: A controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989;160:998-1001.
5. Donaldson RM. Management of medical problems in pregnancy - Inflammatory bowel disease. N Engl J Med 1985;312:1616-1619.
6. Miller JP. Inflammatory bowel disease in pregnancy: A review. J R Soc Med 1986;79:221-225.
7. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term randomized, double blind study. N Engl J Med 1980;302:981-987.
8. Present DH, Meltzer SJ, Krumholtz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med 1989;111:641-649.
9. Korelitz BI. Antimetabolites in inflammatory bowel disease: Long-term experience. Mt Sinai J Med 1990;57:297-304.
10. George J, Present DH, Pou R, Bodian C, Rubin PH. The long term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 1990;132:1111-1119.
11. Modigliani R. Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol 1997;9:854-857.
12. Hawthorne AB, Logan RFA, Hawkey CJ, Foster PN, Axon, Swarbrick ET, Scott BB, Lennard-Jones JE. Randomized controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992;305:20-22.
13. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis. Ann Intern Med 1995;122:132-142.
14. Platzek T, Bochert. Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice. Teratog Carcinog Mutagen 1996;16:169-181.
15. Voogd CE. Azathioprine, a genotoxic agent to be considered non-genotoxic in man. Mutat Res 1989;221:133-152.
16. Mosesso P, Palitti F. The genetic toxicology of 6-mercaptopurine. Mutat Res 1993;296:279-294.
17. Cuffari C, Hunt S, Bayless T. Utilization of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut 2001;48:642-646.
18. Meehan RT, Dorsey JK. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 1987;14:259-262.
19. Scantleburg V, Gordon R, Tzakis A, Koneru B, Bowan J, Mazzaferro V, Stevenson WC, Todo S, Iwatsuki S, Starzl TE. Childbearing after liver transplantation. Transplantation 1990;49:317-321.
20. Roubenoff R, Hoyt J, Petri M, Hochberg MC, Hellman DB. Effects of anti-inflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum 1988;18:88-110.
21. Williamson RA, Karp LE. Azathioprine teratogenicity: Review of the literature and case report. Obstet Gynecol 1981;58:247-250.
22. Rayburn WF. Connective tissue disorders and pregnancy. J Reprod Med 1998;43:341-349.
23. Hou S. Pregnancy in women with chronic renal disease. N Engl J Med 1985;312:836-839.
24. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999;33:235-252.
25. Willis FR, Findlay CA, Gorrie MJ, Watson MA, Wilkinson AG, Beattie TJ. Children of renal transplant recipient mothers. J Paediatr Child Health 2000;36:230-235.
26. Ghandour FZ, Knauss TC, Hricik DE. Immunosuppressive drugs in pregnancy. Adv Ren Replace Ther 1998;5:31-37.
27. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995;38:1727-1732.
28. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJG, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443-446.
29. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GM. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000;95:684-688.
30. Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, Moser G. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001;121:1048-1053.
31. Scott JR, Di Daia PJ, Hammond CB, Spellacy WN. Danforth's Obstetrics and Gynecology. 8th Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999.
32. New York State Department of Health Congenital Malformations Registry Annual Report. Statistical Summary of Children Born in 1995 and Diagnosed Through 1997. Center for Environmental Health Bureau of Environmental and Occupational Epidemiology, 1999.
33. Walsh PC, Retik AB, Vaughan EV, Wein AJ. Campbell's Urology. 7th Ed. Phildelphia, PA: Saunders, 1998.
34. Olsen KO, Juul S, Berntsson I, Oresland T, Luarberg S. Ulcerative colitis: Female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002;122:15-19.
35. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Brief report: Treatment of chronic inflammatory bowel disease in glycogen storage disease type lb with colony-stimulating factors. N Engl J Med 1992;326:1666-1669.
36. Ben-Neriah Z. WAGR syndrome in a baby: The result of 6-MP treatment in a father affected by Crohn's disease? (letter) Am J Gastroenterol 2001;96:251.
37. Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res 2001;264:74-99.
38. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993;21:172-181.
39. Carmi R, Gohar J, Meizner I, Katz M. Spontaneous abortion - High risk factor for neural tube defects in subsequent pregnancy. Am J Med Genet 1995;51:93-97.
40. Sheiner E, Miriam K, Fraser D, Gohar J, Carmi R. The relationship between congenital cardiovascular malformations and spontaneous abortion in preceding pregnancy. Paediatr Perinat Epidemiol 1998;12:128-135.
41. Bianca S, Ettore G, Guarnera S, Meli S, Mollica F. The relationship between congenital cardiovascular malformations and spontaneous abortion in preceding pregnancy (letter). Paediatr Perinat Epidemiol 1999;13:236.
42. Goldstein SR, Kerenyi T, Scher J, Papp C. Correlation between karyotype and ultrasound findings in patients with failed early pregnancy. Ultrasound Obstet Gynecol 1996;8:314-317.
43. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G. The safety of mesalamine in human pregnancy: A prospective controlled cohort study. Gastroenterology 1998;114:23-28.
44. Marteau P, Tennenbaum R, Elefant E, Lemann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998;12:1101-1108.
45. Colombel JF, Brabant G, Gubler MC, Locquet A, Comes MC, Dehennault M, Delcroix M. Renal insufficiency in infant: Side-effect of prenatal exposure to mesalazine? Lancet 1994;344:620-621.
46. Connell WR. Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women. Inflamm Bowel Dis 1996;2:33-47.
47. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteriods on fetal outcome. Gastroenterology 1981;80:72-76.
48. Rodriquez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: A case-control study. Teratology 1998;58:2-5.
49. Pilarski LM, Yacyshyn BR, Lazarovits AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azthioprine in utero. Transplantation 1994;57:133-144.
50. Albengres E, Le Louet H, Tillement JP. Immunosuppressive drugs and pregnancy: Experimental and clinical data. Transplant Proc 1997;29:2461-2466.
51. Davison JM. Pregnancy in renal allograft recipients: Prognosis and management. Baillieres Clin Obstet Gynecol 1987;1:1027-1035.
52. O'Donoghue VP, Dawson AM, Powell-Tuck J, Bown RL, Lennard-Jones JE. Double blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978;2:955-957.